Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2002-05-31
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Dietary Protein Intake in Elderly Adults
NCT03765710
Assessment of Dietary Protein Needs of Older Women
NCT01193946
Determination of Protein Requirement in Elderly Male Subjects >75 Yrs Old
NCT01948492
Diet and Muscle Function In Older Adults
NCT02069314
The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women
NCT00421408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Young men, age 21-46 years.
Lower Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a lower protein diet.
Medium Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a medium protein diet.
Higher Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a higher protein diet.
2
Old Men, age 63-81 years.
Lower Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a lower protein diet.
Medium Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a medium protein diet.
Higher Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a higher protein diet.
3
Young women, age 21-46 years.
Lower Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a lower protein diet.
Medium Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a medium protein diet.
Higher Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a higher protein diet.
4
Old women, age 63-81 years.
Lower Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a lower protein diet.
Medium Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a medium protein diet.
Higher Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a higher protein diet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lower Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a lower protein diet.
Medium Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a medium protein diet.
Higher Protein
Each subject completed an 18-day periods (trials) of strict dietary control of consuming a higher protein diet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not diagnosed with diabetes or metabolic syndrome
* Clinically normal blood laboratory values
Exclusion Criteria
* BMI: 20-29 kg/m
* Weight stable: \<2kg change within the last 3 months
* Physical Activity: constant habitual pattern, no deviation \>1x week of 30/minute sessions within the last 3 months
Clinically abnormal values:
* Blood
* Urine
Also, exclude any:
* Using meds that would influence appetite
* Using any anti-inflammatory steroid medications
* Has a joint replacement
* A medical condition that might place them at risk for participating in the study or interfere with successful completion of the study
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wayne Campbell
Prof. Foods and Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00-226
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.